Alzheimer’s Drug Lecanemab Wins FDA Approval
Lecanemab (Leqembi) was approved under the accelerated approval pathway to treat Alzheimer’s disease, the FDA announced on Friday. The anti-amyloid should be started only in patients with mild cognitive impairment or who are at the mild dementia stage of Alzheimer’s disease, the population studied in clinical trials, the agency noted, and the drug label indicates […]
Scientists discover new avian immunological pathway
A research team led by a biomedical scientist at the University of California, Riverside, has discovered a new immune pathway in chickens that viruses — such as those that tend to infect birds, humans, and animals and spread diseases like influenza or Crimean-Congo hemorrhagic fever — may be targeting. The discovery, which has implications also […]